In a recent development, the Trump administration has decided to terminate $129 million in funding for Duke University’s HIV vaccine research efforts. This decision comes after a review by the National Institutes of Health (NIH) leadership, who have chosen not to support the consortia for HIV/AIDS vaccine development and immunology. The move has raised concerns within the scientific community about the impact on ongoing research and the potential setbacks in the quest for an effective HIV vaccine. With vaccine development being a critical area of focus in the fight against HIV/AIDS, the implications of this funding cut are significant and could have far-reaching consequences. Researchers and advocates in the field are now left grappling with the implications of this decision and exploring alternative funding sources to continue their important work in combating the global HIV epidemic.
Read more about this — here
